Hostname: page-component-586b7cd67f-tf8b9 Total loading time: 0 Render date: 2024-11-30T23:34:15.089Z Has data issue: false hasContentIssue false
  • English
  • Français

Adverse selection in a start-up long-term care insurance market

Published online by Cambridge University Press:  19 November 2014

C. Adams ,
C. Donnelly  and
A. Macdonald
Get access Rights & Permissions [Opens in a new window]

Abstract

Common to all previous studies assessing the cost of adverse selection associated with genetics has been the assumption of an established market, i.e., the adverse selectors have been buying insurance at that rate for such a period that premiums have already absorbed it. Their analyses involve calculating the percentage difference between premiums in a market with adverse selection and one without adverse selection. They can shed no light on how the premiums would get to this stage over time and what losses might be incurred in the process. We take the modelling further by outlining a multiple state Markov model for a start-up market of long-term care insurance. With this model, we explicitly show the progression of adverse selection costs using the development of information that an insurer would gain from analysing the claims history of its existing business, to reprice premiums for new business. To overcome the complication of insurance benefit amounts, which depend on the value of previous benefit payments, we develop a simulation approach of estimating the expected present values of insurance benefits and premium payments. In applying our modelling to a UK setting, we find genetic testing of the apolipoprotein E gene (whose variants can cause a high risk of developing dementia) to be of a relatively small impact compared with our hypothetical state of intermediate dementia progression. Furthermore, we find that the government’s cap on care costs has little effect on adverse selection costs as it benefits only a small proportion of people.

Keywords

Genetics and InsuranceAdverse SelectionLong-Term CareAlzheimer’s Disease
Type
Sessional meetings: papers and abstracts of discussions
Information
British Actuarial Journal , Volume 20 , Issue 2 , July 2015 , pp. 298 - 347
Copyright
© Institute and Faculty of Actuaries 2014 

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

Adams, C. (2013). Adverse selection in insurance markets with genetic information. PhD thesis, Heriot-Watt University, Edinburgh.Google Scholar
Adams, C.J., Donnelly, C. & Macdonald, A.S. (2013). The impact of known breast cancer polygenes on critical illness insurance. Scandinavian Actuarial Jou rnal, 1–31.Google Scholar
Akodu, O. (2007). A stochastic & dynamic projection model of long-term care demand and cost in the United Kingdom. PhD thesis, Heriot-Watt University, Edinburgh.Google Scholar
Alagiakrishnan, K., Gill, S.S. & Fagarasanu, A. (2012). Genetics and epigenetics of Alzheimer’s disease. Postgraduate Medical Journal, 88, 522–529.Google ScholarPubMed
Ballard, C., O’Brien, C., Barber, R., Neill, D. & McKeith, I. (2001). The progression of cognitive impairment in dementia with Lewy bodies, vascular dementia and Alzheimer’s disease. International Journal of Geriatric Psychiatry, 16, 499–503.CrossRefGoogle ScholarPubMed
Barclay, L.L., Zemcov, A., Blass, J.P. & Sansone, J. (1985). Survival in Alzheimer’s disease and vascular dementias. Neurology, 350(6), 834–834.CrossRefGoogle Scholar
Berr, C., Wancata, J. & Ritchie, K. (2005). Prevalence of dementia in the edlerly in Europe. European Neuropsychopharmacology, 15, 463–471.CrossRefGoogle Scholar
Bochkanov, S. & Bystritsky, V. (2013). Alglib, available at www.alglib.netGoogle Scholar
Bracco, L., Gallato, R., Grigoletto, F., Lippi, A., Lepore, V., Bino, G., Lazzaro, M.P., Carella, F., Piccolo, T., Pozzilli, C., Giometto, B. & Amaducci, L. (1994). Factors affecting course and survival in Alzheimer’s disease: a 9-year longitudinal study. Archives of Neurology, 51(12), 1213–1219.CrossRefGoogle ScholarPubMed
Brown, J.R. & Finkelstein, A. (2009). The private market for long-term care insurance in the United States: a review of the evidence. Journal of Risk and Insurance, 76(1), 5–29.CrossRefGoogle ScholarPubMed
Burns, A. (1993). Survival in dementia, in Ageing and Dementia: A Methodological Approach. chapter 7 (ed. E. Arnold), Taylor and Francis, London, pp. 125–143.Google Scholar
Burns, A., Lewis, G., Jacoby, R. & Levy, R. (1991). Factors affecting survival in Alzheimer’s disease. Psychological Medicine, 21(2), 363–370.CrossRefGoogle ScholarPubMed
Colgan, G. (2006). Analysis of medical interventions in Alzheimer’s disease as the affect long-term care. Institute and Faculty of Actuaries, London.Google Scholar
Comas-Herrera, A., Wittenberg, R., Pickard, L. & Knapp, M., MRC-CFAS (2003). Cognitive impairment in older people: its implications for future demand for services and costs. Discussion Paper No. 1782/2, PSSRU, London.Google Scholar
Commission on Funding of Care and Support (2010). Call for evidence on the future funding of care and support, July.Google Scholar
Commission on Funding of Care and Support (2011). Fairer care funding, July. http://webarchive.nationalarchives.gov.uk/20130221130239/http://www.dilnotcommission.dh.gov.uk/our-report/Google Scholar
Continuous Mortality Investigation (1990). Standard Tables of Mortality Based on the 1979–82 Experiences. Continuous mortality investigation reports No. 10, Continuous Mortality Investigation, London.Google Scholar
Continuous Mortality Investigation (2009). Graduations of the 1999–2002 life office mortality experiences: the 00 series tables. Continuous mortality investigation reports No. 23.Google Scholar
Continuous Mortality Investigation (CMI) (2011). The CMI mortality projections model, Working Paper No. 55, Continuous Mortality Investigation, September, London.Google Scholar
Coon, K., Myers, A., Craig, D., Webster, J., Pearson, J., Lince, D., Zismann, V., Beach, T., Leung, D., Bryden, L., Halperin, R., Marlowe, L., Kaleem, M., Walker, D., Ravid, R., Heward, C., Rogers, J., Papassotiropoulos, A., Reiman, E., Hardy, J. & Stephan, D. (2007). A high-density whole-genome association study reveals that APOE is the major susceptibility gene for sporadic late-onset Alzheimer’s disease. Journal of Clinical Psychiatry, 68(4), 613–618.CrossRefGoogle ScholarPubMed
Copeland, J., McCracken, C., Dewey, M., Wilson, K., Doran, M., Gilmore, C., Scott, A. & Larkin, B. (1999). Undifferentiated dementia, Alzheimer’s disease and vascular dementia: age and gender-related incidence in Liverpool – the MRC-ALPHA study. British Journal of Psychiatry, 175, 433–438.Google ScholarPubMed
Courbage, C. & Roudaut, N. (2008). Empirical evidence on long-term care insurance purchase in France. The Geneva Papers on Risk and Insurance – Issues and Practice, 33(4), 645–658.CrossRefGoogle Scholar
Devroye, L. (1986). Non-Uniform Random Variate Generation. New York, NY: Springer-Verlag.CrossRefGoogle Scholar
Diesfeldt, H., Houte, L. & Moerkens, R. (1986). Duration of survival in senile dementia. Acta Psychiatrica Scandinavica, 73(4), 366–371.CrossRefGoogle ScholarPubMed
European Court of Justice (2011). European Court Reports 2011 I-00773. C-236/09 Association Belge des Consommateurs Test-Achats ASBL.Google Scholar
Farrer, L.A., Brin, M.F., Goate, A., Kennedy, J., Mayeux, R., Myers, R.H., Reilly, P. & Risch, N.J. (1995). Statement on use of apolipoprotein E testing for Alzheimer disease. Journal of the American Medical Association, 274(20), 1627–1629.CrossRefGoogle Scholar
Farrer, L.A., Cupples, L.A., Haines, J.L., Hyman, B., Kukull, W.A., Mayeux, R., Myers, R.H., Pericak-Vance, M.A., Risch, N. & van Duijn, C.M. (1997). Effects of age, sex, and ethnicity on the association between apolipoprotein e genotype and Alzheimer disease. A meta-analysis. APOE and Alzheimer disease meta analysis consortium. Journal of the American Medical Association, 278(16), 1349–1356.CrossRefGoogle ScholarPubMed
Finkelstein, A. & McGarry, K. (2006). Multiple dimensions of private information: evidence from the long-term care insurance market. American Economics Review, 96, 938–958.CrossRefGoogle ScholarPubMed
Forder, J. & Fernández, J.-L. (2009). Analysing the costs and benefits of social care funding arrangements in England: technical report. Discussion Paper No. 2644, PSSRU, London.Google Scholar
Gatz, M., Reynolds, C., Fratiglioni, L., Johansson, B., Mortimer, J., Berg, S., Fiske, A. & Pedersen, N. (2006). Role of genes and environments for explaining Alzheimer disease. Archives of General Psychiatry, 63(2), 168–174.CrossRefGoogle ScholarPubMed
Guillén, M. & Comas-Herrera, A. (2012). How much risk is mitigated by LTC protection schemes? A methodological note and a case study of the public system in Spain. The Geneva Papers on Risk and Insurance – Issues and Practice, 37(4), 712–724.CrossRefGoogle Scholar
Guillen, M. & Pinquet, J. (2008). Long-term care: risk description of a Spanish portfolio and economic analysis of the timing of insurance purchase. The Geneva Papers on Risk and Insurance – Issues and Practice, 33(4), 659–672.CrossRefGoogle Scholar
Hancock, R., Wittenberg, R., Pickard, L., Comas-Herrera, A., Juarez-Garcia, A., King, D. & Malley, J. (2007). Paying for long-term care for older people in the UK: modelling the costs and distributional effects of a range of options. Discussion Paper No. 2336/2, PSSRU, London.Google Scholar
Helms, F., Czado, C. & Gschlossl, S. (2005). Calculation of LTC premiums based on direct estimates of transition probabilities. ASTIN Bulletin, 35(2), 455–469.CrossRefGoogle Scholar
Heyman, A., Peterson, B., Fillenbaum, G. & Pieper, C. (1996). The Consortium to Establish a Registry for Alzheimer’s Disease (CERAD). Part XIV demographic and clinical predictors of survival in patients with Alzheimer’s disease. Neurology, 46(3), 656–660.CrossRefGoogle Scholar
Huang, Y. & Mucke, L. (2012). Alzheimer mechanisms and therapeutic strategies. Cell, 148(6), 1204–1222.CrossRefGoogle ScholarPubMed
Jones, K. (2006). The cost of providing home care, in Unit Costs of Health & Social Care 2005 (ed. Lesley Curtis and Ann Netten), pp. 9–12. Personal Social Services Research Unit, University of Kent, Kent.Google Scholar
Katz, S., Downs, T.D., Cash, H.R. & Grotz, R.C. (1970). Progress in development of the index of ADL. The Gerontologist, 10(1), 20–30.Google ScholarPubMed
Kofler, B.M., Miles, E.A., Curtis, P., Armah, C.K., Tricon, S., Grew, J., Napper, F.L., Farrell, L., Lietz, G., Packard, C.J., Caslake, M.J., Mathers, J.C., Williams, C.M., Calder, P.C. & Minihane, A.M. (2012). Apolipoprotein E genotype and the cardiovascular disease risk phenotype: impact of sex and adiposity (the FINGEN study). Atherosclerosis, 221(2), 467–470.CrossRefGoogle ScholarPubMed
Launer, L., Andersen, K., Dewey, M., Letenneur, L., Ott, A., Amaducci, L., Brayne, C., Copeland, J., Dartigues, J., Kragh-Sorensen, P., Lobo, A., Martinez-Lage, J., Stijnen, T. & Hofman, A., and EURODEM Incidence Res Grp Work Grp (1999). Rates and risk factors for dementia and Alzheimer’s disease results from EURODEM pooled analyses. Neurology, 52(1), 78–84.CrossRefGoogle ScholarPubMed
Launer, L.J. (1992). Overview of incidence studies of dementia conducted in Europe. Neuroepidemiology, 11(Suppl 1), 2–13.CrossRefGoogle ScholarPubMed
Laing & Buisson (2011). Domiciliary care UK market report. Retrieved June 5, 2013 from http://www.payingforcare.orgGoogle Scholar
Laing & Buisson (2012/2013). Care of elderly people report. Retrieved June 5, 2013 from http://www.payingforcare.orgGoogle Scholar
Lloyd, J. (2011). Gone for good? Pre-funded insurance for long-term care, Strategic Society Centre, London.Google Scholar
Low, L.-F., Yap, M.H. & Brodaty, H. (2010). Will testing for apolipoprotein E assist in tailoring dementia risk reduction? A review. Neuroscience and Biobehavioral Reviews, 34(3), 408–437.Google ScholarPubMed
Macdonald, A.S. & Pritchard, D. (2000). A mathematical model of Alzheimer’s disease and the APOE gene. ASTIN Bulletin, 30, 69–110.CrossRefGoogle Scholar
Macdonald, A.S. & Pritchard, D. (2001). Genetics, Alzheimer’s disease, and long-term care insurance. North American Actuarial Journal, 5(2), 54–78.CrossRefGoogle Scholar
Mahoney, F.I. & Barthel, D.W. (1965). Functional evaluation: the Barthel index. Maryland State Medical Journal, 14, 61–65.Google ScholarPubMed
Manolio, T.A., Chisholm, R.L., Ozenberger, B., Roden, D.M., Williams, M.S., Wilson, R., Bick, D., Bottinger, E.P., Brilliant, M.H., Eng, C., Frazer, K.A., Korf, B., Ledbetter, D.H., Lupski, J.R., Marsh, C., Mrazek, D., Murray, M.F., O’Donnell, P.H., Rader, D.J., Relling, M.V., Shuldiner, A.R., Valle, D., Weinshilboum, R., Green, E.D. & Ginsburg, G.S. (2013). Implementing genomic medicine in the clinic: the future is here. Genetics in Medicine, 15(4), 258–267.CrossRefGoogle Scholar
Manton, K.G. (1988). A longitudinal study of functional change and mortality in the United States. Journal of Gerontology, 43(5), S153–S161.Google ScholarPubMed
Matthews, F.E., Arthur, A., Barnes, L.E., Bond, J., Jagger, C., Robinson, L. & Brayne, C. (2013). A two-decade comparison of prevalence of dementia in individuals aged 65 years and older from three geographical areas of England: results of the cognitive function and ageing study i and {II}. The Lancet, 382(9902), 1405–1412.CrossRefGoogle ScholarPubMed
Nuttall, S.R., Blackwood, R.J.L., Bussell, B.M.H., Cliff, J.P., Cornall, M.J., Cowley, A., Gatenby, P.L. & Webber, J.M. (1994). Financing long-term care in Great Britain. Journal of the Institute of Actuaries, 121(1), 1–68.CrossRefGoogle Scholar
Office for National Statistics (2011). 2010-based national population projections. Retrieved June 5, 2013 from http://www.ons.gov.uk/ons/publications/re-reference-tables.html?edition=tcm %3A77-229071Google Scholar
Office for National Statistics (2012a). Population estimates for UK, England and Wales, Scotland and Northern Ireland, population density tables, 1981 to 2010. Retrieved June 5, 2013 from http://www.ons.gov.uk/ons/publications/re-reference-tables.html?edition=tcm%3A77-268725Google Scholar
Office for National Statistics (2012b). Mortality in England and Wales: Average Life Span, 2010. Retrieved June 5, 2013 from http://www.ons.gov.uk/ons/rel/mortality-ageing/mortality-in-england-and-wales/average-life-span/rpt-average-life-span.htmlGoogle Scholar
Office for National Statistics (2013). Average weekly earnings dataset. Retrieved June 5, 2013 from http://www.ons.gov.uk/ons/rel/lms/labour-market-statistics/january-2013/dataset--earnings.htmlGoogle Scholar
Oster, E., Shoulson, I., Quaid, K. & Dorsey, E.R. (2010). Genetic adverse selection: evidence from long-term care insurance and Huntington disease. Journal of Public Economics, 94, 1041–1050.CrossRefGoogle Scholar
Pauly, M.V. (1990). The rational nonpurchase of long-term-care insurance. Journal of Political Economy, 98(1), 153–168.CrossRefGoogle Scholar
Pritchard, D. (2006). Modeling disability in long-term care insurance. North American Actuarial Journal, 10(4), 48–75.CrossRefGoogle Scholar
Rickayzen, B. & Walsh, D. (2002). A multi-state model of disability for the United Kingdom: implications for the future need for long term care for the elderly. British Actuarial Journal, 8(11), 341–393.CrossRefGoogle Scholar
Royal Commission on Long Term Care (1999). With Respect to Old Age: Long Term Care: Rights and Responsibilities. vol. 1 Stationery Office/TSO, London.Google Scholar
Sayetta, R.B. (1986). Rates of senile dementia – Alzheimer’s type in the Baltimore longitudinal study. Journal of Chronic Diseases, 39(4), 271–286.CrossRefGoogle ScholarPubMed
Song, Y., Stampfer, M.J. & Liu, S. (2004). Meta-analysis: apolipoprotein e genotypes and risk for coronary heart disease. Annals of Internal Medicine, 141(2), 137–147.CrossRefGoogle ScholarPubMed
Walsh, J.S., Welch, H.G. & Larson, E.B. (1990). Survival of outpatients with Alzheimer-type dementia. Annals of Internal Medicine, 113(6), 429–434.CrossRefGoogle ScholarPubMed
Ward, H., Mitrou, P.N., Bowman, R., Luben, R., Wareham, N.J., Tee Khaw, K. & Bingham, S. (2009). APOE genotype, lipids, and coronary heart disease risk: a prospective population study. Archives of Internal Medicine, 169(15), 1424–1429.CrossRefGoogle Scholar
Wittenberg, R., Comas-Herrera, A., King, D., Malley, J., Pickard, L. & Darton, R. (2006). Future demand for long-term care, 2002 to 2041: projections of demand for long-term care for older people in england. Discussion Paper No. 2330, PSSRU, London.Google Scholar
Wittenberg, R., Pickard, L., Comas-Herrera, A., Davies, B. & Darton, R. (1998). Demand for Long-Term Care: Projections of Long-Term Care Finance for Elderly People. Canterbury: Personal Social Services Research Unit.Google Scholar
Zhou-Richter, T., Browne, M.J. & Gründl, H. (2010). Don’t they care? Or, are they just unaware? Risk perception and the demand for long-term care insurance. Journal of Risk and Insurance, 77(4), 715–747.CrossRefGoogle Scholar
Zick, C.D., Mathews, C.J., Roberts, J.S., Cook-Deegan, R., Pokorski, R.J. & Green, R.C. (2005). Genetic testing for Alzheimer’s disease and its impact on insurance purchasing behavior. Health Affairs, 24(2), 483–490.CrossRefGoogle ScholarPubMed